HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recovery from carcinomatous meningitis by erlotinib.

AuthorsGen Ohara, Katsunori Kagohashi, Koichi Kurishima, Mio Kawaguchi, Hidetsugu Nakayama, Hiroaki Satoh
JournalOnkologie (Onkologie) Vol. 34 Issue 7 Pg. 394-5 ( 2011) ISSN: 1423-0240 [Electronic] Switzerland
PMID21734429 (Publication Type: Case Reports, Letter)
Chemical References
  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride
Topics
  • Adenocarcinoma (drug therapy, secondary)
  • Aged
  • Brain Neoplasms (drug therapy, secondary)
  • Erlotinib Hydrochloride
  • Female
  • Humans
  • Lung Neoplasms (drug therapy)
  • Meningeal Carcinomatosis (drug therapy, secondary)
  • Protein Kinase Inhibitors (therapeutic use)
  • Quinazolines (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: